21 April 2024>: Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, and High-Income Countries: A Systematic Review
Abdul Khairul Rizki Purba 123ABCDEF* , Alfian Nur Rosyid 4ABCEF , Samsriyaningsih Handayani 5ABCDF , Brian Eka Rachman 6BC , Achmad Chusnu Romdhoni 7CD , Makhyan Jibril Al Farabi 8CD , Joni Wahyuhadi 9CD , Rosita Prananingtias 10BEF , Ainun Nitsa Rahayu 11BEF , Firas Farisi Alkaff 1213CD , Yufi Aulia Azmi 1415CD , Sabarinah Prasetyo 16EG , Mardiati Nadjib 17DE , Lina Patricia Gutjahr 18EF , Raudia Faridah Humaidy 19CDDOI: 10.12659/MSM.943863
Med Sci Monit 2024; 30:e943863
Table 1 Characteristics of selected studies.
No. | Author, year | COVID-19 Surveillance Methods | Country | Year of publication | Age | N | Specificity | Sensitivity |
---|---|---|---|---|---|---|---|---|
1 | Chaki et al, 2022 []21 | Molecular receptor-binding motif-targeted Sanger sequencing | USA | 2022 | N/A | 20 | N/A | N/A |
2 | Drakesmith et al, 2022 []27 | Lateral flow devices for asymptomatic SARS-CoV-2 infections | UK | 2022 | Aged 11 years or over | 48 834 tests | 99% | 40% |
3 | Du et al, 2021 []22 | SARS-Cov-2 testing strategies in the USA | USA | 2021 | Stratified into age of 5–17, 18–49, 50–64, and 65 years and older | 129 697 households | 90% | 99% |
4 | Larremaore et al, 2021 []23 | Olfactory testing | USA | 2021 | N/A | 10 000 simulations | 80–96% | N/A |
5 | Lyng et al, 2021 []24 | Nucleic acid amplification tests in school and business | USA | 2021 | N/A | N/A | 90–99.5% | 98% and 60% |
6 | Simonetti et al, 2021 []28 | Cov-Seq (genomic surveillance) | Italy | 2021 | N/A | 274 samples | N/A | 95.40% |
7 | Schaaf et al, 2021 []25 | Pooled saliva | USA | 2021 | 18 to 24 year-olds (college-age students) | 43 884 samples | N/A | N/A |
8 | Wang et al, 2022 []26 | Large-side sports competition, covid 19 surveillance strategy (nucleic acid test) | China | 2022 | 18–22 years old | N/A | N/A | N/A |
N/A – not applicable. |